When Marybeth Gilliam was diagnosed with metastatic breast cancer, she did what her years as a healthcare researcher had trained her to do: she went looking for the evidence. What she found was a gap between a growing body of peer-reviewed research pointing to strategies that can improve outcomes, and the fact that most of it never reached patients because it hadn't yet become standard of care.In this episode of Patient From Hell, host Samira Daswani sits down with Marybeth, founder of Outperform Cancer, to talk about how she is working to close that gap. She translates overlooked, peer-reviewed findings into steps patients can actually take, always paired with standard treatment rather than in place of it. Exercise, nutrition, and sleep are part of it, and so is asking sharper questions about biomarker testing, weighing well-supported off-label options, and refusing to take no for an answer when the data is strong.She shares her own story, the research that reshaped her thinking, and a practical case for taking an active role in your care when the first treatment decisions matter most.In this episode:Why she founded Outperform Cancer to close the gap between research and the clinicHow she pairs evidence-based strategies with standard treatment, not instead of itBiomarker testing and advocating for off-label options backed by solid trials (PATINA, MA.32)What being your own advocate actually looks like in the exam roomThis podcast is for general informational purposes only and does not constitute medical advice. The opinions of the speakers are their own.

CHAPTERS

00:00 The overlooked risk factor after childbirth

00:39 Meet Marybeth Gilliam

00:53 Why she founded Outperform Cancer

02:15 The cancer care information gap

02:20 The exercise discovery that changed everything

04:14 Her metastatic breast cancer diagnosis

06:11 Looking back at her 2007 Stage 0 diagnosis

07:16 Postpartum breast cancer and recurrence risk10:36 Building an anti-cancer strategy

13:58 From metastatic diagnosis to NED

15:48 Exercise, sleep, nutrition, and lifestyle changes18:24 Creating an anti-cancer environment20:03 The PATINA trial explained

23:24 Accessing promising therapies before standard of care

25:46 How patients can advocate for themselves

27:51 The 15-year research-to-practice gap

28:45 Precision medicine and biomarker testing

30:42 The ATM gene and metformin research

32:08 Stacking interventions: what does the evidence say?

33:08 Balancing risk, reward, and patient choice

35:24 Lessons from cancer innovators and patient-led research

37:00 Final thoughts and takeaways

Follow Patient From Hell for more conversations on cancer, survivorship, patient advocacy, research breakthroughs, and navigating healthcare with confidence.

Understanding postpartum breast cancer risks is critical. Learn why a diagnosis within 10 years of childbirth changes prognosis.

Many patients do not realize that postpartum breast cancer is defined as a diagnosis within 10 years of having children. This video explains the medical reasoning behind why these patients face a significantly higher likelihood of recurrence compared to other groups. We specifically look at the data showing that even stage one patients are three times more prone to metastasis during this specific window.

Welcome to the Patient from Hell podcast! Live from ASCO 2026, we explore breakthroughs in clinical oncology, cancer research, AI healthcare tools, and targeted therapy for advanced cancer.

Samira Daswani, Founder and CEO of Manta Cares and host of The Patient From Hell, sits down with Dr. Doug Blayney, Chief Medical Officer of Manta Cares and former ASCO President, for a candid debrief in between sessions at the 2026 ASCO Annual Meeting in Chicago.

With 45,000 oncology professionals in attendance, ASCO is the largest gathering of cancer researchers and clinicians in the world. In this episode, Samira and Dr. Blayney break down what actually mattered: the clinical findings, the shifting treatment landscape, and what the research trends mean for patients navigating cancer today.

This episode is for oncologists, cancer researchers, and anyone who wants to understand where the field is heading.

Topics covered, with more to come in our next episode:

• Key clinical findings from ASCO 2026
• Trends shaping experimental and clinical oncology
• What high attendance and collaboration signals for the future of cancer research
• What patients should know coming out of this year's conference

CHAPTERS:0:00 - ASCO 2026 Annual Meeting Live from Chicago0:27 - Artificial Intelligence (AI) in Oncology & Patient Experience1:19 - Healthcare AI Challenges: Misinformation & Clinician Deskilling2:03 - Pancreatic Cancer Breakthrough: New RAS/KRAS Targeted Therapy2:30 - Lung Cancer Advancements: ALK Mutations & PD-L1 Data3:01 - Breast Cancer Innovation: Oral SERDs & ESR1 Biomarkers3:41 - Next Episode Preview & Wrap Up

Subscribe for frequent breakdowns of cancer research, treatment news, patient stories, and guidance and support for people in treatment for cancer. Drop a comment with the topics or trials you want us to cover next!

What happens when a medical doctor trained in oncology becomes the cancer patient and then transforms into a primary caregiver for his own father? In this moving continuation of our conversation with clinician, survivor, and care partner Dr. Achim, we dive into the profound emotional architecture of navigating a cancer diagnosis. Dr. Achim opens up about the vast difference between his first experience as a helpless care partner for his father’s prostate cancer in 2010, and his recent role guiding his 85-year-old father through aggressive lymphoma and groundbreaking CAR T-cell therapy.Samira and Dr. Achim explore a topic rarely discussed openly in the oncology world: the long, arduous journey of rebuilding trust in your body after it feels like it has completely betrayed you. Dr. Achim shares how shifting from anger to radical self-love and mastering the art of strict presence—learning to live purely in the current moment—became his ultimate armor against the paralyzing fear of cancer recurrence. Whether you are a patient looking for tools to manage treatment intervals, a male patient looking for permission to voice your fears, or a caregiver trying to balance medical advocacy with emotional support, this episode offers an essential roadmap for finding steady footing when your world is turned upside down.Chapter Codes:00:00 Grounding in the Present Moment00:44 Dr. Achim's Transition From Patient to Caregiver02:15 The Reality of Being a Cancer Care Partner06:46 Navigating Aggressive Lymphoma & CAR T-Cell Therapy09:57 Healing the Feeling of "Body Betrayal"13:49 Mind-Body Visualizations During the Treatment Time Gap15:36 Overcoming the Fear of Cancer Recurrence19:33 Mental Health Stigmas for Male Cancer Patients25:25 Life with No Evidence of Disease (NED)Key Takeaways from This Episode:The Caregiver Shift: Why true caregiving isn't about having all the answers or trying to "fix" the disease; it is about steady, radical presence and holding a hand through the confusion.The "Betrayal" of the Body:Understanding the mental shift required to stop treating your body like an enemy and realizing that it is still actively fighting for you.The Power of Visualizations:How Dr. Achim used a 5-day Carl Simonton method seminar to train his mind during the critical "time gap" between diagnosis and treatment.Connect with Manta Cares & Patient from Hell:Learn more about our mission: Manta Cares WebsiteDiscover your personal cancer roadmap: Patient from Hell Podcast HubSubscribe, rate, and review on Apple Podcasts, Spotify, and YouTube!Disclaimer: This podcast, show notes, and newsletter are for general informational purposes only and do not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. The use of information on this podcast or any materials linked from it is at the user's own risk. The opinions of the speakers are their own and do not represent the organizations they are affiliated with, nor do they reflect the opinions of Manta Cares Inc. or its sponsors.